Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | TOP2A | P11388 | 1/20 | 0.38 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3124491 | 1.00 | ADRA2C (0.51) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL29845931 | 1.00 | ADRA2C (0.51) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL29481560 | 1.00 | ADRA2C (0.51) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL29481563 | 1.00 | ADRA2C (0.51) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL7460986 | 1.00 | ADRA2C (0.51) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL28831343 | 0.87 | ADRA2C (0.43) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL16372279 | 0.84 | ADRA2C (0.49) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL10396657 | 0.83 | LMNA (0.53) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL11452909 | 0.83 | ADRA2C (0.51) | ADRA2CTP53LMNAHTTKCNH2 | |
| SCHEMBL7453698 | 0.83 | ADRA2C (0.51) | ADRA2CTP53LMNAHTTKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116370512-B | Celery seed extract, preparation method thereof and application thereof in uric acid reduction | 湖州草本连自然疗法研究院 | 2023-09-29 | — | — | CN | claimed |
| CN-116370512-A | Celery seed extract, preparation method thereof and application thereof in uric acid reduction | 湖州草本连自然疗法研究院 | 2023-07-04 | — | — | CN | claimed |
| CN-111073912-B | Biological preparation method of (S) -2-chloro-1- (2,4-dichlorophenyl) ethanol | 上海医药工业研究院 | 2022-03-25 | — | — | CN | claimed |
| CN-109574797-B | Preparation method of chiral benzyl alcohol | 上海彩迩文生化科技有限公司 | 2021-09-17 | — | — | CN | claimed |
| CN-111875595-A | Preparation method of azole antifungal drug | 上海福乐医药科技有限公司 | 2020-11-03 | — | — | CN | claimed |
| CN-111073912-A | Biological preparation method of (S) -2-chloro-1- (2,4-dichlorophenyl) ethanol | 上海医药工业研究院 | 2020-04-28 | — | — | CN | claimed |
| CN-117323271-B | Acne-removing composition, and preparation method and application thereof | 广州百孚润化工有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117323271-A | Acne-removing composition, and preparation method and application thereof | 广州百孚润化工有限公司 | 2024-01-02 | — | — | CN | disclosed |
| CN-116370512-B | Celery seed extract, preparation method thereof and application thereof in uric acid reduction | 湖州草本连自然疗法研究院 | 2023-09-29 | — | — | CN | disclosed |
| CN-116370512-A | Celery seed extract, preparation method thereof and application thereof in uric acid reduction | 湖州草本连自然疗法研究院 | 2023-07-04 | — | — | CN | disclosed |
| CN-115028586-A | Preparation method of chiral (S) -imazalil | 池州中瑞化工有限公司 | 2022-09-09 | — | — | CN | disclosed |
| US-20220235082-A1 | CATALYSTS | THE UNIVERSITY OF WARWICK (GB) | 2022-07-28 | — | — | US | disclosed |
| CN-111073912-B | Biological preparation method of (S) -2-chloro-1- (2,4-dichlorophenyl) ethanol | 上海医药工业研究院 | 2022-03-25 | — | — | CN | disclosed |
| EP-1143798-A1 | CHIRAL IMIDAZOLE FUNGICIDAL COMPOSITIONS AND METHODS FOR THEIR USE | CELGENE CORPORATION (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6207695-B1 | INHIBITING GROWTH OF FUNGUS IN ASSOCIATION WITH A PLANT COMPRISING APPLYING TO THE LOCUS OF A PLANT A FUNGICIDALLY EFFECTIVE AMOUNT OF THE (S)-ENANTIOMER OF 1-(2-(2,4-DICHLOROPHENYL)-2-(2-PROPENYLOXY)ETHYL)-1H-IMIDAZOLE | CELGENE CORPORATION | 2001-03-27 | — | — | US | disclosed |
| EP-1026135-A1 | Production of optically active 2-halo-1-(substituted phenyl)-ethanol and substituted styrene oxide | Nihon Nohyaku Co., Ltd. (JP) | 2000-08-09 | — | — | EP | disclosed |
| WO-2000038521-A1 | CHIRAL IMIDAZOLE FUNGICIDAL COMPOSITIONS AND METHODS FOR THEIR USE | CELGENE CORPORATION (US) | 2000-07-06 | — | — | WO | disclosed |
| US-5981807-A | REACTING A HALO-SUBSTITUTED PHENYLETHANOL WITH PHTHALIC ANHYDRIDE, PERFORMING OPTICAL RESOLUTION ON THE RESULTING COMPOUND USING AN OPTICALLY ACTIVE ORGANIC AMINE AS A RESOLVING AGENT, PERFORMING HYDROLYSIS OR ALCOHOLYSIS | NIHON NOHYAKU CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| US-5756862-A | RACEMIZATION WITH ACID CATALYST | NIHON NOHYAKU CO., LTD. (JP) | 1998-05-26 | — | — | US | disclosed |
| EP-0763513-A2 | Production of optically active 2-halo-1-(substituted phenyl)-ethanol and substituted styrene oxide | Nihon Nohyaku Co., Ltd. (JP) | 1997-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220235082-A1 | CATALYSTS | TST, TCP1, CCT3 | ADRA2C 4277/4885TP53 2513/4885LMNA 1391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.